Year: 2025
Type: article
Abstract: Background: Amidst a global resurgence of diphtheria cases with numerous outbreaks recorded worldwide since 2000, a better understanding of this vaccine-preventable disease's circulation is needed. Methods: We retrospectively analyzed sera from 2 sero-epidemiological cross-sectional studies in Madagascar and Cambodia on fully primo-vaccinated 3- to 15-year-olds. Using enzyme-linked immunosorbent assay (ELISA) and seroneutralization (Vero Cell TNT) for the 3- to 8-year-olds with low ELISA titration values (<0.01 IU/mL), we assessed (i) the duration of protection by primary vaccination for 3- to 8-year-olds and (ii) the level of diphtheria in children and adolescents. Seropositivity was defined as a titration value (by ELISA or TNT) of at least 0.1 IU/mL and was used as a proxy for diphtheria infection among individuals >6 years postvaccination. Results: < .01) in Madagascar. In Cambodia and Madagascar, respectively, 27.8% and 20.7% of the participants whose primary vaccination was performed >6 years earlier were seropositive, suggesting diphtheria infection. In both countries, we observed a higher rate of infected children when the last vaccine injection had been received 7-8 years or 11-12 years earlier vs 5-6 years earlier. Conclusions: Our data show that the disease is present at high levels in Cambodia and Madagascar and that the national recommendation-primary vaccination-is not sufficient: Booster doses appear necessary at around 6 years of age and for adolescents, as recommended by the World Health Organization.
Source: Open Forum Infectious Diseases
DOI: 10.1093/ofid/ofaf091
Institutions: Institut Pasteur, Université Paris Cité, Institut Pasteur de Madagascar, Institut Pasteur du Cambodge, Centre National de la Recherche Scientifique, Université de Montpellier, Maladies Infectieuses et Vecteurs: Écologie, Génétique, Évolution et Contrôle, Institut de Recherche pour le Développement, Johns Hopkins University, Johns Hopkins Medicine
Language: English
Subfield: Endocrinology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $4,053
Funders: Total, Total Foundation
OpenAlex ID: W4408140402
